Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 29047
Evènement :Pharmacokinetics/Biopharmaceutics for Chemists/Analysts

Date :Jeudi 21 Février 2019

Lieu :Palo Alto
2479 East Bayshore Road,
Suite 200
94303 Palo Alto, California, États-Unis

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

Editorial

This training program will focus on defining and explaining numerous concepts and terminologies in a simple language as related to the safety, efficacy and quality assessment of pharmaceutical products for human use. It will also describe the necessity of understanding the basic physiological concepts pertinent to drug actions, product developments and evaluations.

Objectives

Pharmaceutical product developments and assessments require extensive analytical data to establish quality, safety and efficacy of the products. These data are generated by laboratory facilities (internal as well as external to manufacturers) which often lack needed physiological and biological expertise/understanding leading to poor study or experimental design followed by inaccurate interpretation of results. Therefore, current practices are not only causing significant waste of time and frustration within industry and regulatory authorities but delays in product approvals and financial losses for the manufacturers. This webinar is designed to address these deficiencies.

The attendees will have clear understanding of underlying science so that they would be able design the experimental studies appropriately followed by efficient and accurate interpretation of the results. Differences in drugs/medicines and their products will be explained so that kinetic models can be applied appropriately. Terminologies commonly used will be explained in detail with an overview of applicable regulatory requirements and practices.  

Program

  • Describing and defining pharmacokinetics and biopharmaceutics
  • Overview of relevant cardiovascular and gastrointestinal physiology
  • Importance and necessity of clear understanding of relevance of physiology and pharmacokinetics for analysts
  • Differentiating drugs/medicines from drug/medicinal products concerning safety, efficacy and quality aspects
  • Describing journey of a drug through the body and its compartmentalization
  • Explaining commonly used terminologies-I: drug absorption, distribution, metabolism and elimination
  • Explaining commonly used terminologies-II: plasma drug concentration-time profile, area under the curve (AUC), Cmax, Tmax, apparent volume of distribution, elimination rate constant, half-life
  • Assessment of drug products: Innovators vs generic, concepts of bioavailability/bioequivalence, in vitro-in vivo evaluations
  • Overview of regulatory requirements and guidance’s

Speakers

Saeed Qureshi

Saeed Qureshi
Principal, PharmacoMechanics

Dr. Saeed Qureshi has extensive (30+ years) working experience, as a research scientist, with a regulatory agency (Health Canada). He is an internationally known expert on the subject and maintains a full command in the areas of drug dissolution testing, pharmacokinetics, biopharmaceutics and analytical chemistry as related to animal and human studies for developing and evaluating pharmaceutical products. His areas of expertise include: (1) Quality assessment of pharmaceutical products based on pharmacokinetic studies (e.g. bioavailability/bioequivalence) in humans and animals, including validation of in vitro results with in vivo (bioavailability) studies. (2) In vitro drug release characterization of pharmaceutical products in particular oral and dermal using dissolution and/or diffusion (absorption/penetration through skin) techniques. (3) Analytical methods development/validation for drug disposition evaluation in humans and animals using chromatographic (e.g. HPLC, GC, TLC) and spectroscopic (e.g. UV, MS) techniques. (4) Data analysis using sophisticated (SAS) and general-purpose (e.g. MS Excel) software.

Dr. Qureshi has extensively published in peer-reviewed journals and given numerous national and international presentations on the subject. Dr. Qureshi is very well known for his innovative but simple and practical ideas. Since 2010, he has been contributing and moderating a weblog (www.drug-dissolution-testing.com) which has become a popular source of new and thought provoking ideas for addressing the issues of product evaluations.

Since 2015 Dr. Qureshi has been working as an independent consultant. A detailed description of his expertise and the services he provides may be obtained from the website (www.pharmacomechanics.com).

 
 

Lieu

Plan et itinéraire
Adresse de la conférence :
Palo Alto
2479 East Bayshore Road,
Suite 200
94303 Palo Alto
California, États-Unis
Tél : +1-888-717-2436
Plan et itinéraire

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

Pharmacokinetics/Biopharmaceutics for Chemists/Analysts Management
pharmacokinetics training, bioavailability and bioequivalence studies, drug development regulatory requirements, biopharmaceutics training
Professionnels, Pharmaceutical Development Setting up Analytical Methods (Pharmacopeial, Regulatory or in-house developed) R & D, Both analytical and formulation Project Management Quality Control Quality Assurance Regulatory Affairs
10 -- --
English

Divers

Pour plus d'informations sur Pharmacokinetics/Biopharmaceutics for Chemists/Analysts, veuillez contacter ComplianceOnline

Pour afficher le site de l'annonceur, obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama


Recommander cet évènement